Early Phase 1 Cardiovascular Disease Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Single-tracer Multiparametric PET Imaging

Cardiovascular DiseaseHealthy Subjects

University of California, Davis60 enrolled1 locationNCT06014515

Recruiting

Early Phase 1

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients

Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes

Cyclarity Therapeutics, Inc.84 enrolled1 locationNCT06813339

Recruiting

Early Phase 1

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

Cardiovascular DiseasesHypertension

University of Minnesota80 enrolled1 locationNCT06507657